Skip to content

Clinical trials

Bipolar Disorder trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Country / region: India Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
20063
20071
20094
20102
20112
20151
20201
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.5
All India Institute of Medical Sciences, Bhubaneswar2
AstraZeneca2
Intra-Cellular Therapies, Inc.2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Bristol-Myers Squibb1
Eli Lilly and Company1
Forest Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder22
Mania3
Schizophrenia2
Major Depressive Disorder1

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.